HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Uwe Haberkorn Selected Research

(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)

2/2015Comparison of ⁶⁸Ga-DOTATOC-PET/CT and PET/MRI hybrid systems in patients with cranial meningioma: Initial results.
8/2014Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.
9/2012Detection of cranial meningiomas: comparison of ⁶⁸Ga-DOTATOC PET/CT and contrast-enhanced MRI.
10/2011Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastases.
5/2010Intraindividual comparison of selective arterial versus venous 68Ga-DOTATOC PET/CT in patients with gastroenteropancreatic neuroendocrine tumors.
7/2006Quantitative assessment of SSTR2 expression in patients with non-small cell lung cancer using(68)Ga-DOTATOC PET and comparison with (18)F-FDG PET.
5/2006Improved target volume definition for fractionated stereotactic radiotherapy in patients with intracranial meningiomas by correlation of CT, MRI, and [68Ga]-DOTATOC-PET.
1/2003Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe(1)-Tyr(3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Uwe Haberkorn Research Topics

Disease

72Neoplasms (Cancer)
11/2015 - 01/2003
16Prostatic Neoplasms (Prostate Cancer)
01/2016 - 01/2005
12Hepatocellular Carcinoma (Hepatoma)
01/2014 - 05/2003
10Neoplasm Metastasis (Metastasis)
03/2015 - 01/2003
9Melanoma (Melanoma, Malignant)
03/2015 - 12/2002
8Carcinoma (Carcinomatosis)
11/2015 - 03/2002
7Experimental Liver Neoplasms
01/2007 - 05/2003
6Neuroendocrine Tumors (Neuroendocrine Tumor)
08/2014 - 01/2003
5Meningioma (Meningiomas)
02/2015 - 05/2005
5Colorectal Neoplasms (Colorectal Cancer)
01/2012 - 08/2008
4Anoxia (Hypoxia)
01/2015 - 01/2010
4Glioma (Gliomas)
03/2014 - 12/2010
4Alzheimer Disease (Alzheimer's Disease)
02/2013 - 10/2003
4Thyroid Neoplasms (Thyroid Cancer)
11/2012 - 05/2004
3Adenocarcinoma
03/2015 - 01/2011
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2015 - 07/2006
3Multiple Myeloma
07/2014 - 09/2009
3Amyloidosis
05/2014 - 12/2007
3Lung Neoplasms (Lung Cancer)
04/2014 - 09/2007
3Astrocytoma (Pilocytic Astrocytoma)
03/2014 - 11/2002
3Sarcoma (Soft Tissue Sarcoma)
08/2010 - 03/2008
3Experimental Melanoma
12/2006 - 10/2004
2Heart Failure
09/2014 - 05/2013
2Infection
01/2014 - 03/2008
2Dementia (Dementias)
02/2013 - 04/2011
2Necrosis
01/2012 - 12/2011
2Lymphoma (Lymphomas)
11/2011 - 04/2007
1Breast Neoplasms (Breast Cancer)
11/2015
1Hypertrophy
09/2014
1Pancreatic Neoplasms (Pancreatic Cancer)
07/2014

Drug/Important Bio-Agent (IBA)

17PeptidesIBA
08/2013 - 01/2005
16Glucose (Dextrose)FDA LinkGeneric
07/2014 - 03/2002
9human glutamate carboxypeptidase IIIBA
01/2016 - 01/2012
9Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
03/2015 - 03/2002
8(DOTA(0)-Phe(1)-Tyr(3))octreotide (SMT 487)IBA
02/2015 - 01/2003
7LigandsIBA
06/2015 - 01/2010
6Somatostatin Receptors (Somatostatin Receptor)IBA
01/2015 - 01/2003
5BenzamidesIBA
01/2014 - 12/2002
5sodium-iodide symporter (sodium iodide symporter)IBA
12/2010 - 05/2003
4N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
01/2016 - 04/2012
4Carbonic Anhydrases (Carbonic Anhydrase)IBA
01/2012 - 01/2010
4BombesinIBA
02/2011 - 01/2005
3Urea (Carbamide)FDA LinkGeneric
01/2016 - 01/2012
3AntibodiesIBA
03/2015 - 11/2011
3Bombesin Receptors (Bombesin Receptor)IBA
05/2014 - 04/2005
3Prealbumin (Transthyretin)IBA
05/2014 - 12/2007
3benzamideIBA
01/2014 - 12/2002
3Melanins (Melanin)IBA
01/2014 - 10/2005
3Proteins (Proteins, Gene)IBA
01/2012 - 01/2007
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2010 - 05/2005
3DNA (Deoxyribonucleic Acid)IBA
09/2006 - 03/2005
3hygromycin AIBA
05/2004 - 05/2003
3Tyrosine (L-Tyrosine)FDA Link
04/2004 - 03/2002
2Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2015 - 01/2012
2Peptide Receptors (Peptide Receptor)IBA
08/2014 - 06/2007
2GadoliniumIBA
05/2014 - 01/2007
2Choline (Choline Chloride)IBA
01/2014 - 12/2010
2Protons (Proton)IBA
04/2013 - 04/2004
2cetuximab (Erbitux)FDA Link
01/2012 - 07/2011
2Histone Deacetylase InhibitorsIBA
01/2012 - 12/2010
2Annexin A5IBA
12/2011 - 12/2010
2Radioisotopes (Radionuclides)IBA
11/2011 - 05/2005
2ThymidineIBA
12/2010 - 03/2005
2IfosfamideFDA LinkGeneric
08/2010 - 04/2010
2Doxorubicin (Adriamycin)FDA LinkGeneric
08/2010 - 04/2010
2Octreotide (Sandostatin)FDA LinkGeneric
05/2010 - 01/2005
2Deoxyglucose (2 Deoxy D glucose)IBA
11/2009 - 04/2009
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2008 - 03/2005
2Angiopoietin-2IBA
08/2008 - 09/2006
2imatinib (Gleevec)FDA Link
08/2007 - 06/2007
2Gadolinium DTPA (Magnevist)FDA Link
01/2007 - 11/2002
2Dacarbazine (DIC)FDA LinkGeneric
12/2006 - 10/2004
2Chlorambucil (Leukeran)FDA Link
12/2006 - 10/2004
2Monophenol Monooxygenase (Tyrosinase)IBA
10/2005 - 06/2004
2Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2004 - 05/2003
1Fatty Acid Synthetase Complex (Fatty Acid Synthase)IBA
11/2015
1CeruleninIBA
11/2015
1LutetiumIBA
05/2015
1Epidermal Growth Factor (EGF)IBA
03/2015
1ipilimumabIBA
03/2015
1Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
03/2015
12-(phosphonomethyl)pentanedioic acidIBA
02/2015
1pinacolyl methylphosphonic acidIBA
02/2015
1pimonidazoleIBA
01/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2015
1fluoromisonidazoleIBA
01/2015
1Endothelin Receptors (Endothelin Receptor)IBA
09/2014
1Endothelin-1 (Endothelin 1)IBA
09/2014
1gemcitabineFDA Link
07/2014
1bromopyruvateIBA
07/2014
1aldehyde dehydrogenase 1IBA
07/2014
1Adenosine Triphosphate (ATP)IBA
07/2014
1Sodium Fluoride (Ossin)FDA Link
07/2014

Therapy/Procedure

16Radiotherapy
01/2016 - 11/2002
11Drug Therapy (Chemotherapy)
07/2015 - 12/2006
9Heterologous Transplantation (Xenotransplantation)
03/2015 - 04/2005
2Aftercare (After-Treatment)
11/2012 - 01/2012
2Radioimmunotherapy
11/2011 - 07/2011
2Intraperitoneal Injections
12/2006 - 05/2006
2Gamma Cameras (Gamma Camera)
05/2006 - 05/2006